Max Chat
Share chart InspireMD, Inc.
Extended chart
Simple chart
About InspireMD, Inc.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Delivery System, a mesh-covered self-expanding carotid stent; SwitchGuard, a non-invasive transcarotid artery revascularization device; and NGuard EPS for treating acute stroke with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.Main settings
IPO date
2011-04-12
ISIN
US45779A8466
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 15.79 | 1 |
| P/BV | 3.07 | 5 |
| P/E | 71.09 | 1 |
Efficiency
| Title | Value | Grade |
| ROA | 3.3 | 1 |
| ROE | 4.12 | 1 |
| ROIC | 0 | 0 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0 | 0 |
| DSI | 0 | 0 |
| Average dividend growth | 0 | 0 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | -0.0698 | 10 |
| Debt/Ratio | 0.0499 | 10 |
| Debt/Equity | 0.2971 | 10 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 180.36 | 10 |
| Yield Ebitda, % | 222.14 | 10 |
| Yield EPS, % | -100.53 | 0 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 2.32 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| Week | 2.45 $ | 0 $ | 0 $ | -5.31 % | 0 % | 0 % |
| Month | 2.53 $ | 2.32 $ | 2.32 $ | -8.3 % | 0 % | 0 % |
| Three month | 2.56 $ | 2.19 $ | 2.7 $ | -9.38 % | 0 % | 0 % |
| Half a year | 2.76 $ | 2.19 $ | 3.7 $ | -15.94 % | 0 % | 0 % |
| Year | 2.84 $ | 2.19 $ | 3.7 $ | -18.31 % | 0 % | 0 % |
| 3 years | 1.86 $ | 0.81 $ | 3.77 $ | +24.73 % | 0 % | 0 % |
| 5 years | 0.47 $ | 0.29 $ | 6.92 $ | +393.62 % | 0 % | 0 % |
| 10 years | 0.0023 $ | 0.0023 $ | 7.14 $ | +100 869.56 % | 0 % | 0 % |
| Year to date | 2.43 $ | 2.19 $ | 3.7 $ | -4.53 % | 0 % | 0 % |
Main owners
| Institutions | Volume | Share, % |
| Nantahala Capital Management, LLC | 4 132 912 | 17.62 |
| Orbimed Advisors LLC. | 2 133 405 | 9.1 |
| Marshall Wace LLP | 1 860 405 | 7.93 |
| Soleus Capital Management, L.P. | 1 378 128 | 5.88 |
| Rosalind Advisors, Inc. | 925 194 | 3.94 |
| Velan Capital Investment Management LP | 904 029 | 3.85 |
| PURA VIDA INVESTMENTS, LLC | 450 517 | 1.92 |
| Millennium Management LLC | 348 274 | 1.48 |
| Morgan Stanley | 63 530 | 0.27 |
| Mesirow Financial Investment Management, Inc. | 30 000 | 0.13 |
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Marvin L. Slosman | President, CEO & Director | 843.83k | 1964 (61 year) |
| Mr. Craig Shore | CFO, Chief Administrative Officer, Secretary & Treasurer | 613.49k | 1961 (64 years) |
| Mr. Andrea Tommasoli | Chief Operating Officer | 359.27k | 1972 (53 years) |
| Mr. Amir Kohen | Senior Vice President of Finance & HR | N/A | |
| Mr. Shane Thomas Gleason | Chief Commercial Officer | 486.04k | 1975 (50 years) |
| Dr. Patrick A. Verta DVM, M.D., MS Stat | Executive Vice President of Clinical & Medical Affairs | N/A | 1958 (67 years) |
| Dr. Sol J. Barer Ph.D. | Special Advisor to the Board | 13.92k | 1947 (78 years) |
| Mr. Pete J. Ligotti | Executive VP & GM of North America |
About company
Address: Israel, Tel Aviv, 4 Menorat Hamaor Street - Open in google maps, Open in yandex maps
Website: https://www.inspiremd.com
Website: https://www.inspiremd.com
